See discussions, stats, and author profiles for this publication at: https://www.researchgate.

net/publication/368868685

Adherence to Post-polypectomy Surveillance Guidelines at a Large District

General Hospital

Article in Cureus · February 2023

DOI: 10.7759/cureus.35516

CITATIONS READS

0 10,055

5 authors, including:

Aye Myat Myintmo Harriet Flashman

Royal Devon and Exeter NHS Foundation Trust University of Exeter
10 PUBLICATIONS 23 CITATIONS 2 PUBLICATIONS 0 CITATIONS

SEE PROFILE SEE PROFILE

All content following this page was uploaded by Aye Myat Myintmo on 02 March 2023.

The user has requested enhancement of the downloaded file.

 Open Access Original
Article DOI: 10.7759/cureus.35516

Adherence to Post-polypectomy Surveillance

Guidelines at a Large District General Hospital
Review began 02/04/2023
Daniel M. Butler 1 , Aye Myintmo 1 , Harriet Flashman 2 , Obioha C. Ukoumunne 2 , Rob Bethune 1
Review ended 02/16/2023
Published 02/27/2023 1. Colorectal Surgery, Royal Devon University Healthcare NHS Foundation Trust, Exeter, GBR 2. Faculty of Health and
© Copyright 2023 Life Sciences, University of Exeter Medical School, Exeter, GBR
Butler et al. This is an open access article
distributed under the terms of the Creative Corresponding author: Daniel M. Butler, [email protected]
Commons Attribution License CC-BY 4.0.,
which permits unrestricted use, distribution,
and reproduction in any medium, provided
the original author and source are credited.
Abstract
Introduction
In 2020, the British Society of Gastroenterologists (BSG), the Association of Coloproctology of Great Britain
and Ireland (ACPGBI), and Public Health England (PHE) published joint guidelines regarding post-
polypectomy surveillance. This study aimed to establish clinician adherence at the Royal Devon University
Healthcare NHS Foundation Trust to the 2020 guidelines compared to the now-retired 2010 guidelines.

Materials and Methods

Data on 152 patients treated under the 2010 guidelines and 133 patients treated under the 2020 guidelines
were collected retrospectively from the hospital’s colonoscopy database. Data were analysed to determine
whether patients who had a colonoscopy fulfilled BSG/ACPGBI/PHE guidelines for follow-up. Costs were
estimated using the price of colonoscopy in the NHS National Schedule.

Results
Approximately 41.4% (63/152) of patients were adherent to the 2010 guidelines while 66.2% (88/133) of
patients were adherent to the 2020 guidelines. The difference in adherence rate was 24.7% (95% confidence
interval 13.5% - 35.9%, p<0.0001).

Nearly 37% (35/95) of patients who would have been followed up under the 2010 guidelines did not receive
any follow-up as a result of the 2020 guidelines. This represents a cost saving of £36,892.28 per year in our
hospital. Approximately 47% (28/60) of patients treated under the 2020 guidelines had surveillance
colonoscopy planned when the guidelines recommended no follow-up. If every clinician were fully adherent
to the 2020 guidelines, then a further £29,513.82 per year would have been saved.

Discussion and Conclusion

Following the introduction of the 2020 guidelines, adherence to polyp surveillance guidelines increased in
our hospital. However, nearly half of the colonoscopies were performed unnecessarily due to non-adherence.
Furthermore, our results demonstrate that the 2020 guidelines have decreased the need for follow-up.

Categories: Gastroenterology, General Surgery

Keywords: colonoscopy surveillance, cost saving, physician guideline adherence, colon cancer prevention, colorectal
polyp

Introduction
Colorectal polyps are abnormal growths of cells that form on the inside of the colon or rectum. Some
colorectal polyps have the potential to develop into colorectal cancer [1]. The incidence of colorectal cancer
in the UK is 40,000 people per year [2]. The majority of colorectal cancers arise from colorectal polyps [3]. A
majority of the polyps discovered during colonoscopy are removed. Follow-up after polypectomy is referred
to as post-polypectomy surveillance colonoscopy. Polyps are followed up depending on their number, size,
and histological grade. Guidelines exist to determine the appropriate follow-up.

Surveillance guidelines and adherence

In early 2020, the British Society of Gastroenterologists (BSG), the Association of Coloproctology of Great
Britain and Ireland (ACPGBI), and Public Health England (PHE) published joint guidelines regarding post-
polypectomy surveillance [4]. This replaced the previously widely-used guidelines by the BSG/ACPGBI
published in 2002 [5] and updated in 2010 [6]. The 2002 guidelines and the 2010 update stratified
colonoscopy findings into four categories: high, intermediate, low, and no risk. The category would
determine the timing of follow-up. The 2020 guidelines were simplified into two categories: high and no-risk
findings. The 2020 guidelines were the first to consider the role of the National Bowel Cancer Screening

How to cite this article

Butler D M, Myintmo A, Flashman H, et al. (February 27, 2023) Adherence to Post-polypectomy Surveillance Guidelines at a Large District General
Hospital. Cureus 15(2): e35516. DOI 10.7759/cureus.35516
 programme in detecting early cancers. Furthermore, it takes into account evidence to suggest that patients
with low-risk polyps that are removed during initial colonoscopy have an equal chance of developing
colorectal cancer as the general population [7].

Adherence to such guidelines is important, but previous research demonstrates poor adherence [8,9]. One
systematic review and meta-analysis showed that over 50% of surveillance colonoscopies are performed too
soon or too late [10].

Colonoscopies are unpleasant and expensive, and if unnecessary will delay the diagnosis and treatment of
other patients who truly require investigation. Colonoscopies have small but significant risks associated
with them. One study showed that the side effects of bleeding were 1:400, bowel perforation (needing
surgery) 1:2,000, and death 1:30,000 [11]. Furthermore, the cost of each therapeutic colonoscopy is around
£700 according to the NHS National cost schedule [12].

Aim
The aim of this study was to determine clinician adherence to the 2020 BSG/ACPGBI/PHE guidelines
compared to the 2010 guidelines. Data were also examined to discover the number and cost of colonoscopies
saved as a result of the 2020 guidelines.

This article was previously presented as a meeting poster at the 2022 Association of Surgeons of Great
Britain and Ireland (ASGBI) Annual Conference on 3rd May 2022.

Materials And Methods

A retrospective review was undertaken of data collected from the Royal Devon University Healthcare NHS
Foundation Trust colonoscopy database. The final 150 patients treated under the 2010 guidelines and the
first 150 patients treated under the 2020 guidelines were selected. This sample size is large enough to detect
an improvement in adherence from 40% to 60%, with just over 90% power at the two-sided 5% level of
significance. The assumed percentage adherence under the 2010 guidelines of 40% is at the higher end of the
plausible range, thus resulting in a conservatively large sample size requirement. Patients under the 2010
guidelines were collected over 6 months in 2019. Patients under the 2020 guidelines were collected over 8
months in 2020. Patients were selected if this was their first (baseline) colonoscopy. Each colonoscopy
report was analysed by two authors of this study for findings and follow-up recommendations. A patient was
deemed to be adherent if their colonoscopy report specified a follow-up time interval equal to that
recommended by the guidelines. In total, 166 patients treated under the 2010 guidelines and 143 patients
treated under the 2020 guidelines were selected from the colonoscopy database for analysis.

Patients were excluded from the analysis if: at baseline, colonoscopy malignancy or an alternative diagnosis
was discovered; known familial colorectal cancer; patients underwent incomplete polypectomy or patients
who declined follow-up. After exclusion criteria were applied, 152 and 133 patients treated under the 2010
and 2020 guidelines respectively were included in the study. In each study group, the percentage of patients
for whom adherence was met was reported. The difference in adherence percentage was compared using a
two-sample test of independent proportions using Stata statistical software. Costs were estimated using the
NHS National Schedule of Costs. The unit price of therapeutic colonoscopy, 19 years and over the financial
year 2019/20 was utilised, which was £702.71 per therapeutic colonoscopy [12].

Results
Under the 2010 guidelines, 41.4% (63/152) of patients were adherent. Under the 2020 guidelines, 66.2%
(88/133) of patients were adherent (Figure 1). There was a statistically significant increase in adherence of
24.7% (95% confidence interval 13.5% to 35.9%, p<0.0001).

2023 Butler et al. Cureus 15(2): e35516. DOI 10.7759/cureus.35516 2 of 5

 FIGURE 1: Clinician adherence to Post-polypectomy Surveillance
Guidelines

As seen in Table 1, under the 2010 guidelines, 62% (55/89) of non-adherent patients received surveillance
colonoscopy sooner than recommended and 36% (32/89) of non-adherent patients underwent colonoscopy
later than recommended. Under the 2020 guidelines, 36% (16/45) of non-adherent patients received
surveillance colonoscopy sooner than recommended, and 62% (28/45) of patients received follow-up when it
was not recommended at all.

Guidelines Non-adherent patients Reasons for non-adherence

61.8% (55/89 patients) Colonoscopy sooner than recommended

2010 Guidelines (152 patients) 58.6% (89 patients) non-adherent 2.2% (2/89 patients) Colonoscopy not recommended

36.0% (32/89 patients) Colonoscopy later than recommended

35.6% (16/89 patients) Colonoscopy sooner than recommended

2020 Guidelines (133 patients) 33.8% (45 patients) non-adherent 62.2% (28/89 patients) Colonoscopy not recommended

2.2% (1/89 patients) Colonoscopy later than recommended

TABLE 1: The percentages and numbers of patients non-adherent to Post-polypectomy

Surveillance Guidelines with a breakdown of reasons

Cost estimation
Approximately 37% (35/95) of patients who would have been followed up under the 2010 guidelines did not
receive any follow-up due to the 2020 guidelines. This represents a cost saving of £24,594.85 in the study
group, or £36,892.28 per year in our hospital.

Approximately 47% (28/60) of patients treated under the 2020 guidelines had surveillance colonoscopy
planned when the guidelines recommended no follow-up. This represents an estimated unnecessary
additional cost of £19,675.88 in the study group, or £29,513.82 per year in our hospital.

Discussion
There was a marked increase in adherence to the 2020 BSG/ACPGBI/PHE guidelines compared to the 2010
guidelines. Unusually, for new guidelines, the 2020 update recommends less follow-up. As endoscopy units
are under so much pressure, this may have been the driver for the observed greater adherence. Another
reason might be that the 2020 guidelines are simpler to follow, given there are only two follow-up pathways
rather than four pathways under the 2010 guidelines.

Previously published data shows adherence rates to polyp guidelines are poor, both in the UK and globally.
One British district general hospital demonstrated that the 2002 BSG guidelines were successfully followed
in only 17.7% of patients [13]. An Irish study of 363 polyp patients showed that 44.1% of patients were

2023 Butler et al. Cureus 15(2): e35516. DOI 10.7759/cureus.35516 3 of 5

 adherent to the 2002 guidelines [14]. In a European study of 2,997 patients, only 11% of patients were
adherent to their respective Dutch guidelines [9]. Our data supports these findings.

The most common reason for non-adherence was that surveillance follow-up was planned earlier than
recommended or planned when not recommended at all (Table 1). One possible explanation for this is
clinician anxiety, the desire to follow up with their patients despite a negative result, or perceived patient
anxiety that they might be concerned they have a disease despite the reassuring results of their baseline
colonoscopy.

Performing unnecessary colonoscopies on patients who do not need them is unpleasant and potentially
unsafe. Research shows post-colonoscopy bleeding rates were 1:400, bowel perforation (needing surgery)
rates 1:2,000, and death rates 1:30,000 [11].

We estimated there would be 37% fewer patients followed up in our study group because of the 2020
guidelines compared to the 2010 guidelines with an estimated cost saving of £36,892.28 per year in our
hospital department. However, 47% of patients treated under the 2020 guidelines had planned colonoscopies
that were not recommended, costing an avoidable £19,675.88. Our data indicate that the 2020 guidelines
offer a marked reduction in endoscopy demand for the surveillance of polyps. However, non-adherence still
contributes to unnecessary costs and increases demand on endoscopy services. Increased adherence will
likely mean patients who need their colonoscopy will receive it on time and more colorectal cancers will be
identified at an earlier stage.

Approximately 15% of the 500,000 colonoscopies performed each year in the UK are for polyp surveillance
[4]. If our data are extrapolated nationwide, then the 2020 guidelines could save more than 25,000
colonoscopies each year, the equivalent of £17,500,000.

Limitations
Patients were selected as the final 150 patients treated under the 2010 guidelines and the first 150 patients
treated under the 2020 guidelines in our hospital. This study assumed once the 2020 guidelines were
published, clinicians updated their clinical practice immediately. However, it often takes time and education
for a full department to embrace new guidelines, and therefore, the true rate of adherence to the 2020
guidelines may be higher now than our data.

Cost estimation is made using national average costs published by the NHS national cost collection scheme.
However, there remain additional costs of polyp surveillance which were not included in our estimation such
as histology costs. We decided to use the cost of a ‘therapeutic colonoscopy’ because any colorectal polyps
found on the colonoscopy should be removed. The precise costs are not known, as there are some factors
that could increase the costs (for example multiple colonoscopies) and factors that could decrease costs (for
example when no polyps are found).

Coronavirus Disease 2019 (COVID-19) and the resultant global pandemic occurred simultaneously with the
introduction of the 2020 guidelines. It is likely that COVID-19 did alter the clinician adherence rate to the
2020 guidelines during the pandemic but to what extent is unclear.

Conclusions
This retrospective study shows that clinician adherence to the 2020 BSG/ACPGBI/PHE guidelines has
increased compared to the now-retired 2010 guidelines. However, it is clear that some patients continue to
have an unnecessary follow-up that is unpleasant for them and costly to the National Health Service. Given
that the 2020 guidelines require fewer patients to be followed up, it is paramount that clinicians adhere to
them in order to avoid unnecessary colonoscopies. More work needs to be done to identify and address
clinician barriers to adhering to polyp surveillance guidelines.

Additional Information
Disclosures
Human subjects: Consent was obtained or waived by all participants in this study. Animal subjects: All
authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In
compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services
info: All authors have declared that no financial support was received from any organization for the
submitted work. Financial relationships: All authors have declared that they have no financial
relationships at present or within the previous three years with any organizations that might have an
interest in the submitted work. Other relationships: All authors have declared that there are no other
relationships or activities that could appear to have influenced the submitted work.

Acknowledgements

2023 Butler et al. Cureus 15(2): e35516. DOI 10.7759/cureus.35516 4 of 5

 Obioha Ukoumunne was supported by the National Institute for Health and Care Research Applied Research
View publication stats

Collaboration South West Peninsula. The views expressed are those of the authors and not necessarily those
of the NHS, NIHR or the Department of Health and Social Care.

References
1. Click B, Pinsky PF, Hickey T, Doroudi M, Schoen RE: Association of colonoscopy adenoma findings with
long-term colorectal cancer incidence. JAMA. 2018, 319:2021-31. 10.1001/jama.2018.5809
2. What is Bowel Cancer?. (2021). Accessed: September 24 2022: https://www.cancerresearchuk.org/about-
cancer/bowel-cancer/about-bowel-cancer.
3. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis . Cell. 1990, 61:759-67. 10.1016/0092-
8674(90)90186-I
4. Rutter MD, East J, Rees CJ, et al.: British Society of Gastroenterology/Association of Coloproctology of Great
Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection
surveillance guidelines. Gut. 2020, 69:201-23. 10.1136/gutjnl-2019-319858
5. Atkin WS, Saunders BP: Surveillance guidelines after removal of colorectal adenomatous polyps . Gut. 2002,
51 Suppl 5:V6-9. 10.1136/gut.51.suppl_5.v6
6. Cairns SR, Scholefield JH, Steele RJ, et al.: Guidelines for colorectal cancer screening and surveillance in
moderate and high risk groups (update from 2002). Gut. 2010, 59:666-89. 10.1136/gut.2009.179804
7. Cross AJ, Robbins EC, Pack K, et al.: Long-term colorectal cancer incidence after adenoma removal and the
effects of surveillance on incidence: a multicentre, retrospective, cohort study. Gut. 2020, 69:1645-58.
10.1136/gutjnl-2019-320036
8. Salloum RG, Hornbrook MC, Fishman PA, Ritzwoller DP, O'Keeffe Rossetti MC, Elston Lafata J: Adherence to
surveillance care guidelines after breast and colorectal cancer treatment with curative intent. Cancer. 2012,
118:5644-51. 10.1002/cncr.27544
9. van Heijningen EM, Lansdorp-Vogelaar I, Steyerberg EW, et al.: Adherence to surveillance guidelines after
removal of colorectal adenomas: a large, community-based study. Gut. 2015, 64:1584-92. 10.1136/gutjnl-
2013-306453
10. Djinbachian R, Dubé AJ, Durand M, Camara LR, Panzini B, Bouchard S, von Renteln D: Adherence to post-
polypectomy surveillance guidelines: a systematic review and meta-analysis. Endoscopy. 2019, 51:673-83.
10.1055/a-0865-2082
11. Reumkens A, Rondagh EJ, Bakker CM, Winkens B, Masclee AA, Sanduleanu S: Post-colonoscopy
complications: a systematic review, time trends, and meta-analysis of population-based studies. Am J
Gastroenterol. 2016, 111:1092-101. 10.1038/ajg.2016.234
12. National Cost Collection for the NHS. Accessed: March 21 2022: https://www.england.nhs.uk/national-cost-
collection/.
13. John BJ, Irukulla S, Pilgrim G, Swift I, Abulafi AM: Surveillance colonoscopies for colorectal polyps--too
often, too many! An Audit at a Large District General Hospital. Colorectal Dis. 2008, 10:898-900.
10.1111/j.1463-1318.2008.01516.x
14. O'Connor A, Keane RA, Egan B, et al.: Adherence to colorectal polyp surveillance guidelines: is there a
'scope' to increase the opportunities for screening?. Eur J Cancer Prev. 2011, 20:40-5.
10.1097/CEJ.0b013e32833ecc5f

2023 Butler et al. Cureus 15(2): e35516. DOI 10.7759/cureus.35516 5 of 5